Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-23-000347
Filing Date
2023-02-08
Accepted
2023-02-08 18:23:58
Documents
1
Period of Report
2023-01-30

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form313715002_02082023.html 3  
1 OWNERSHIP DOCUMENT form313715002_02082023.xml 3 5104
  Complete submission text file 0000921895-23-000347.txt   7215
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 8582514400
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017
Business Address 155 EAST 44TH ST, SUITE 1630 NEW YORK NY 10017 2124181881
Rubric Capital Management LP (Reporting) CIK: 0001687509 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-33221 | Film No.: 23600422

Mailing Address 155 EAST 44TH ST., SUITE 1630 NEW YORK NY 10017
Business Address
Rosen David Efraim (Reporting) CIK: 0001898677 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33221 | Film No.: 23600421